Rapid Identification of Carbapenemase Genes Directly from Blood Culture Samples
Authors:
- Ghada A. ZiadGZGhada A. Ziad
- Deena JalalDJDeena Jalal
- Mohamed HashemMHMohamed Hashem
- Ahmed A. SayedASAhmed A. Sayed
- Sally MahfouzSMSally Mahfouz
- Ahmed BayoumiABAhmed Bayoumi
- Maryam LotfiMLMaryam Lotfi
- Omneya HassanainOHOmneya Hassanain
- May TolbaMTMay Tolba
- Youssef MadneyYMYoussef Madney
- Lobna ShalabyLSLobna Shalaby
- Mervat ElananyMEMervat Elanany
Open Access
- 28 September 2025
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 15 (19) , 2480
Abstract
Background/Objectives: The rapid identification of carbapenemase genes directly from positive blood culture (BC) samples shortens the time needed to initiate optimal antimicrobial therapy for Carbapenemase-Producing Enterobacterales (CPE) infections. Several commercial automated PCR systems are available for detecting CPE resistance genes but are expensive. The Xpert® Carba-R assay (Cepheid GeneXpert System) has high sensitivity and specificity for the detection of carbapenamase genes from bacterial colonies or rectal swabs, with an affordable price. This assay was not used for positive BC testing of CPE resistance genes. Whole-Genome Sequencing (WGS) for resistance genes can be used as the gold standard at a research level. In this study, we evaluated the performance of the Xpert® Carba-R assay for the early detection of carbapenamase genes directly from positive BCs, using WGS as the gold standard. Methods: A prospective observational study was conducted at Children’s Cancer Hospital-Egypt (CCHE-57357). All positive BCs underwent direct gram staining and conventional cultures. A total of 590 positive BCs containing Gram-negative rods (GNRs) were identified. The Xpert® Carba-R assay was used to detect carbapenemase genes directly from the positive BC bottle compared with WGS results. Results: Among the 590 GNR specimens, 178 were found to carry carbapenemase genes using the Xpert® Carba-R assay, with results obtained in approximately one hour. The main genotypes detected were blaNDM, blaOXA-48-like, and dual blaNDM/blaOXA-48-like at 27%, 29%, and 33%, respectively. The agreement between Xpert® Carba-R assay and WGS results was almost perfect for the genotype resistance pattern of isolates and individual gene detection. Conclusions: The use of the Xpert® Carba-R assay directly from BC bottles was an easy-to-use, time-saving, affordable tool with high accuracy in identifying carbapenemase genes and, thus, shortens the time needed to initiate optimal antimicrobial therapy for CPE infections.Keywords
Funding Information
- pfizer global medical grants (#54699605)
This publication has 29 references indexed in Scilit:
- An Economic Model to Assess the Cost Impact of Using Xpert Carba-R to Screen Carbapenemase-Producing Enterobacterales in Comparison with Standard of Care, in a National Health Service SettingInfectious Diseases and Therapy, 2025
- Evaluating the impact of rapid antimicrobial susceptibility testing for bloodstream infections: a review of actionability, antibiotic use and patient outcome metricsJournal of Antimicrobial Chemotherapy, 2024
- Mortality, hospital length of stay, and recurrent bloodstream infections associated with extended-spectrum beta-lactamase-producing Escherichia coli in a low prevalence region: A 20-year population-based large cohort studyInternational Journal of Infectious Diseases, 2023
- Comparison of the Clinical Outcomes of Patients With Positive Xpert Carba-R Tests for Carbapenemase-Producing Enterobacterales According to Culture PositivityOpen Forum Infectious Diseases, 2022
- Treatment for carbapenem-resistant Enterobacterales infections: recent advances and future directionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2021
- AMRFinderPlus and the Reference Gene Catalog facilitate examination of the genomic links among antimicrobial resistance, stress response, and virulenceScientific Reports, 2021
- Xpert Carba-R assay for detection of carbapenemase-producing organisms in patients admitted to emergency roomsMedicine, 2020
- The emergence of carbapenemase blaNDM genotype among carbapenem-resistant Enterobacteriaceae isolates from Egyptian cancer patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2020
- Molecular characterization of multidrug-resistant Gram-negative pathogens in three tertiary hospitals in Cairo, EgyptEuropean Journal of Clinical Microbiology & Infectious Diseases, 2020
- Improvement of the Xpert Carba-R Kit for the Detection of Carbapenemase-Producing EnterobacteriaceaeAntimicrobial Agents and Chemotherapy, 2016